Why Ketamine for PMDD? Understanding the Glutamate Connection
Premenstrual Dysphoric Disorder, or PMDD, can feel like losing access to yourself every month.
For some people, the luteal phase — the days or weeks before menstruation — brings a dramatic shift in mood, body, perception, and relational safety. Depression may deepen quickly. Anxiety may become overwhelming. Rage may feel disproportionate, frightening, or hard to contain. Hopelessness may arrive with a force that feels impossible to explain to someone who has not lived through it. For many, PMDD also includes suicidal ideation, shame spirals, intrusive thoughts, relational fear, emotional flooding, and a monthly dread of “here it comes again.”
At Solthera Therapy, one of the questions we hear is: Why ketamine for PMDD?
The honest answer is nuanced. There is currently limited direct research on ketamine specifically as a treatment for PMDD. That does not mean the question is unimportant. It means the science has not yet caught up to what many PMDD sufferers, clinicians, and researchers are trying to understand.
PMDD itself has long been misunderstood, underdiagnosed, minimized, and often treated as “just PMS,” despite the fact that it can be profoundly disabling. The diagnosis is still relatively new in the broader arc of mental health research, and the condition remains under-studied compared with major depression, anxiety disorders, PTSD, and other mood-related conditions.
So when we talk about ketamine-assisted therapy for PMDD, we need to be careful. Ketamine is not a cure for PMDD. It is not a replacement for psychiatric care, gynecological care, hormone-informed medical care, or safety planning when suicidality is present. And ketamine itself is not FDA-approved for PMDD or for psychiatric diagnoses generally, though the ketamine-derived medication esketamine has FDA-approved psychiatric indications under specific conditions and monitoring requirements. The FDA has also warned about risks related to compounded ketamine products, especially when used without appropriate medical supervision.
And yet, ketamine may be worth discussing for some people with PMDD because of what we do know: many PMDD symptoms overlap with depression, anxiety, trauma activation, emotional dysregulation, and suicidal ideation. Ketamine has a growing evidence base for rapid antidepressant effects and reduction of suicidal thoughts in depression, including meta-analytic findings showing reductions in suicidal ideation after treatment in depressed patients.
The bridge between these areas is not certainty. It is clinical possibility.
And one of the most important pieces of that possibility is glutamate.
PMDD Is Not “Just Hormones”
PMDD is often talked about as a hormone problem. That is partly true, but incomplete.
Many people with PMDD do not necessarily have abnormal hormone levels. Instead, current thinking suggests that PMDD may involve an abnormal sensitivity to normal hormonal fluctuations across the menstrual cycle. In other words, the issue may not simply be “too much” or “too little” estrogen or progesterone. It may be how the brain and nervous system respond to cyclical shifts in these hormones and their metabolites.
This distinction matters because it helps explain why PMDD can feel so total. The luteal phase can change not only mood, but perception, threat sensitivity, self-concept, attachment security, sensory tolerance, energy, sleep, and the ability to access self-compassion.
A person may know, intellectually, that their partner loves them. But during PMDD, their brain may insist:
“They hate me.”
“They think I’m too much.”
“I’m ruining everything.”
“I’m bad.”
“I can’t keep doing this.”
“This will never end.”
Those thoughts can feel absolutely convincing in the moment.
This is one reason PMDD treatment often needs more than one layer. Medical treatment may address hormonal cycling, serotonergic pathways, psychiatric symptoms, contraception options, or other biological contributors. Therapy may address trauma, attachment patterns, nervous system regulation, relational repair, self-trust, and the shame that often follows PMDD episodes.
Ketamine-assisted therapy, when appropriate, may offer another layer: a way to work with mood, neuroplasticity, and entrenched emotional patterns during a carefully supported therapeutic process.
The Glutamate Connection: Why Ketamine Works Differently
Traditional antidepressants, particularly SSRIs, are often discussed in relation to serotonin. SSRIs can be helpful for PMDD, and many people use them either continuously or during the luteal phase under medical guidance. For some, they are life-changing. For others, they are only partially effective, poorly tolerated, or insufficient on their own.
Ketamine works differently.
Ketamine interacts primarily with the brain’s glutamate system, especially through its effect on NMDA receptors. Glutamate is the brain’s most abundant excitatory neurotransmitter and is involved in mood regulation, learning, stress response, memory, and neuroplasticity — the brain’s capacity to form new connections and update old patterns. Research into ketamine’s antidepressant effects often focuses on glutamate signaling and downstream neuroplasticity-related processes, though the exact mechanisms remain complex and not fully settled.
This is clinically meaningful because PMDD can feel like a locked loop.
During the luteal phase, a person may enter the same painful mental and emotional sequence month after month:
First, the body shifts.
Then the nervous system becomes more sensitive.
Then stress feels harder to metabolize.
Then old attachment wounds or self-critical beliefs become louder.
Then conflict or withdrawal may happen.
Then shame follows.
Then the person braces for the next month.
Over time, PMDD can create not only symptoms, but anticipatory fear. People begin to dread their own cycle. They may feel grief about the part of the month when they “lose themselves.” They may worry about damaging relationships, parenting, work, or self-trust. They may become afraid of their own mind.
The glutamate connection matters because ketamine may help create a temporary window in which the brain is more flexible. That window does not automatically heal PMDD. But when paired with skilled therapy, it may help some people relate differently to the thoughts, sensations, and emotional parts that become activated during the luteal phase.
At Solthera Therapy, this distinction is central: it is not simply ketamine. It is ketamine-assisted therapy.
The medicine may soften rigidity, interrupt depressive intensity, or create distance from shame-based thinking. The therapy helps the person listen, process, integrate, and build a more compassionate internal response.
Why Timing Ketamine Sessions During the Luteal Phase May Matter
For PMDD, timing is not a minor detail.
The luteal phase is often when symptoms intensify. This may include depression, anxiety, irritability, rage, intrusive thoughts, hopelessness, rejection sensitivity, relational fear, and suicidal ideation. If ketamine-assisted therapy is being considered as an adjunctive treatment for PMDD, it may make clinical sense to explore whether sessions are most useful when timed around the phase of the cycle when symptoms are most active.
The goal is not to “erase” the luteal phase. It is to make the experience more workable.
When ketamine sessions are timed during the luteal phase, the hope may be twofold:
First, there may be some reduction in symptom intensity, especially symptoms that overlap with depression, anxiety, overwhelm, and suicidal thinking.
Second, the therapy can work directly with what is present. Instead of discussing PMDD from a distance after the fact, the person may be able to gently explore the beliefs, fears, somatic sensations, and emotional parts that are alive during the PMDD window.
This can be powerful because PMDD often carries a split between “me most of the month” and “me during PMDD.” Many people feel ashamed of their luteal-phase self. They may describe that self as irrational, destructive, needy, angry, or broken. But from a somatic and parts-based perspective, those activated states are not random. They may be protective. They may be exhausted. They may be sounding alarms. They may be carrying unmet needs that have been ignored for too long.
There can be intelligence in the anger.
There can be intelligence in the sadness.
There can be intelligence in the collapse.
There can be intelligence in the part that says, “I cannot keep doing this alone.”
Ketamine-assisted therapy may help create enough space to listen.
PMDD, Parts Work, and the Shame Spiral
One of the most painful aspects of PMDD is not only the mood shift itself. It is the story that forms around it.
A person may feel rage and then think, “I’m abusive.”
They may feel despair and think, “I’m weak.”
They may need reassurance and think, “I’m too needy.”
They may have suicidal thoughts and think, “I’m dangerous or broken.”
They may struggle in relationship and think, “No one should have to love me.”
These thoughts can become a shame spiral.
In the founder’s clinical framing, one of the most important therapeutic questions is:
What are the beliefs that become so painful to live with during PMDD?
This is where ketamine-assisted therapy can become more than symptom management. It can become a space to meet the internal system differently.
For example, a person may come into a session with the familiar PMDD belief:
“My partner hates me.”
“They think I’m crazy.”
“I’m ruining their life.”
“They should leave me.”
“I am bad.”
During a ketamine-assisted therapy session, that person may experience enough distance from the shame voice to recognize:
“This is a voice in my mind. It feels real, but it may not be true.”
“My partner loves me.”
“I am not bad.”
“This is PMDD.”
“I am worthy of care.”
“This is not my fault.”
“I can get through this.”
That shift may sound simple from the outside. But for someone living with PMDD, even a small increase in spaciousness can matter. It can become the difference between fusing with the shame spiral and being able to say, “A part of me is terrified right now.”
That language matters.
Not “I am terrible.”
But “a part of me is afraid.”
Not “I destroy everything.”
But “a part of me is overwhelmed and needs support.”
Not “I am unlovable.”
But “a shame voice is here, and it needs compassion.”
This is where modalities such as Internal Family Systems-informed therapy, somatic mindfulness, attachment healing, EMDR-informed trauma work, Hakomi, Sensorimotor Psychotherapy, Somatic Experiencing, and nervous-system-informed care can support the ketamine process. The medicine may open a door. The therapy helps the person walk through it with care, pacing, and integration.
Listening to the Symptoms Instead of Fighting Them
Many people with PMDD spend years trying to push symptoms away.
They try not to be angry.
They try not to need anything.
They try not to cry.
They try not to scare their partner.
They try not to inconvenience their family.
They try not to feel the monthly dread.
But pushing symptoms away can add another layer of suffering. The original pain is hard enough. The self-judgment on top of it can become unbearable.
A different question is: What is this activated part trying to communicate?
Maybe the anger is saying, “I need more help.”
Maybe the despair is saying, “I cannot keep carrying this alone.”
Maybe the irritability is saying, “I am overstimulated and need quiet.”
Maybe the relationship panic is saying, “I need reassurance and secure connection.”
Maybe the exhaustion is saying, “My body needs rest before I hit a wall.”
Maybe the resentment is saying, “The household load is not sustainable.”
Maybe the shame is saying, “I need to know I am still lovable when I am struggling.”
This does not mean every PMDD impulse should be acted out. It means symptoms can be approached with curiosity rather than contempt.
In ketamine-assisted therapy, the goal may be to help the person develop a more compassionate internal response:
“I can manage this.”
“I am really angry, and I can listen to what my anger is telling me.”
“There is nothing wrong with me for having PMDD.”
“This is not my fault.”
“I am doing the best I can.”
“I am still a good person.”
“I can ask for support.”
“This wave will pass.”
That kind of internal messaging is not toxic positivity. It is nervous system medicine. It helps interrupt the added injury of self-attack.
Integration: Turning a Ketamine Session Into Luteal-Phase Support
The ketamine experience itself is only one part of the work.
Integration is where insights become practical support for everyday life. After a ketamine-assisted therapy session, integration may explore questions such as:
What did you notice in the session?
Did any beliefs soften or shift?
Did any parts of you feel seen for the first time?
Did you experience compassion toward yourself?
Did you receive an image, phrase, or felt sense that might help during the next luteal phase?
What support needs to be communicated before symptoms peak?
What relational agreements would help?
What should your partner, family, or support system understand about PMDD?
What helps you remember that PMDD thoughts are not always truth?
For someone whose PMDD shame spiral often says, “My partner hates me,” integration might include creating a mantra or anchor statement:
“My partner loves me.”
“I am lovable even when I am struggling.”
“This is PMDD speaking.”
“I am not bad.”
“I can pause before reacting.”
“I can ask for reassurance directly.”
“I can get through this wave.”
For someone whose luteal phase brings rage, integration might include a plan for anger that protects both truth and relationship:
“My anger has information.”
“I do not have to attack to be heard.”
“I can step away and return.”
“I can ask for help with the kids, meals, chores, or sensory overload.”
“I can name what is unfair without shaming myself or someone else.”
For someone who experiences suicidal ideation during PMDD, integration must include a clear safety plan, appropriate clinical collaboration, and emergency resources. Ketamine-assisted therapy should never be treated as a substitute for crisis care.
Ketamine for PMDD Is an Adjunct, Not a Standalone Treatment
This point is essential.
Ketamine-assisted therapy for PMDD should be understood as an adjunctive treatment. That means it may support a broader care plan, but it should not replace medical evaluation or ongoing care with a psychiatrist, primary care physician, OB-GYN, or other qualified medical provider.
PMDD can involve hormonal sensitivity, psychiatric symptoms, trauma history, nervous system dysregulation, sleep disruption, relationship stress, and suicidal ideation. A comprehensive care plan may include psychiatric medication, luteal-phase SSRI dosing, hormonal treatments, cycle tracking, nutrition and sleep support, trauma therapy, couples support, somatic regulation practices, lifestyle modifications, and crisis planning when needed.
Ketamine-assisted therapy may be most appropriate when it is held within that larger web of care.
At Solthera Therapy, the emphasis is not on ketamine as a magic fix. The emphasis is on supported therapeutic work: preparing carefully, collaborating with medical providers when needed, timing sessions thoughtfully, working with what emerges, and integrating insights into daily life.
Who Might Consider Ketamine-Assisted Therapy for PMDD?
Ketamine-assisted therapy may be worth exploring for adults with PMDD who experience significant depression, anxiety, shame spirals, relational distress, trauma activation, or suicidal ideation during the luteal phase, especially when they are already engaged in medical and psychiatric care.
It may be especially relevant for people who say:
“I become someone I don’t recognize before my period.”
“I know the thoughts are PMDD, but I still believe them when they happen.”
“I spiral into shame every month.”
“My relationships suffer during my luteal phase.”
“I dread half my life.”
“I need help finding compassion for the part of me that gets activated.”
“I want support that is not just symptom suppression, but deeper therapeutic work.”
It may not be appropriate for everyone. Careful screening matters. Ketamine has medical and psychological risks, including dissociation, blood pressure changes, sedation, misuse potential, and possible worsening of certain psychiatric symptoms in some individuals. The FDA has specifically highlighted risks with compounded ketamine and unsupervised use, including concerns around sedation, dissociation, vital sign changes, respiratory depression, misuse, and urinary symptoms.
A responsible approach includes medical oversight, informed consent, realistic expectations, and clear collaboration.
A More Compassionate Way to Live With PMDD
For many people, the goal of PMDD treatment is not perfection. It is not never feeling angry, never feeling sad, never needing reassurance, or never having a difficult luteal phase.
The goal is to suffer less.
To have more space between a thought and a reaction.
To recognize PMDD’s voice without fully becoming it.
To ask for support before collapse.
To feel anger without being consumed by it.
To remember love when shame says love is gone.
To move through the luteal phase with less dread and more preparation.
To know: “This is not my fault, and I can care for myself through it.”
Ketamine’s potential role in PMDD is not simply about chemistry, though chemistry matters. The glutamate system, neuroplasticity, mood regulation, and rapid antidepressant effects are all part of the conversation.
But the deeper question is therapeutic:
When PMDD brings the most painful parts of a person to the surface, can those parts be met differently?
Can the rage be heard without destruction?
Can the grief be held without shame?
Can the suicidal thoughts be taken seriously without becoming the whole truth?
Can the body be supported instead of blamed?
Can the person remember, even in the hardest part of the month, “I am still me. I am still worthy. I can get through this”?
For some people, ketamine-assisted therapy may help create the conditions for that remembering.
Not as a cure.
Not as a replacement for comprehensive PMDD care.
But as a carefully held adjunct to therapy, integration, self-compassion, and medical support.
Ketamine-Assisted Therapy for PMDD at Solthera Therapy
Solthera Therapy offers ketamine-assisted therapy and PMDD therapy for clients seeking a compassionate, trauma-informed, and nervous-system-aware approach to cyclical mood distress. Kiri Maura brings an integrative clinical background that includes Somatic Mindfulness Therapy rooted in Buddhist practice, Internal Family Systems-informed work, EMDRIA-trained EMDR, Brainspotting, Hakomi, Sensorimotor Psychotherapy, Somatic Experiencing, attachment healing, Polyvagal-informed regulation, DBT/CBT, Gestalt, Emotionally Focused Therapy, Relational Life Therapy, Non-Violent Communication, harm-reduction approaches, and psychedelic integration.
For clients navigating PMDD, the work may include ketamine-assisted therapy, integration sessions, somatic regulation, parts work, relational communication support, shame reduction, and collaboration with medical providers when appropriate.
Solthera Therapy serves clients in Marin County, San Rafael, the East Bay, Berkeley, California statewide via telehealth, and Washington State. Psychedelic integration support is available virtually across the U.S. and globally where appropriate.
If PMDD makes you dread your luteal phase, you are not broken. Your symptoms deserve to be taken seriously, and your activated parts deserve care.
Learn more about my approach to therapy & coaching for PMDD and trauma therapy.
